Anti-Human CD328/SIGLEC7 Antibody (SAA2438) from ProteoGenix; catalogue ARO-A22885; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for your biotech research needs.
This highly specific antibody targets CD328/SIGLEC7, a cell surface receptor that plays a crucial role in the immune system. It is a member of the sialic acid-binding immunoglobulin-like lectin (SIGLEC) family and is expressed on various immune cells, including natural killer (NK) cells, monocytes, and macrophages.
The Anti-Human CD328/SIGLEC7 Antibody (SAA2438) has been extensively validated for its high specificity and sensitivity in detecting CD328/SIGLEC7 in various human tissues and cell types. Its exceptional binding affinity allows for precise and reliable detection of this important immune receptor.
This antibody is a valuable tool for studying the biological function of CD328/SIGLEC7. It can be used in a variety of applications, including flow cytometry, immunohistochemistry, and western blotting. Its versatility makes it suitable for both in vitro and in vivo experiments, providing researchers with valuable insights into the role of CD328/SIGLEC7 in the immune response.
The Anti-Human CD328/SIGLEC7 Antibody (SAA2438) has been successfully used in various research areas, including cancer immunology, infectious diseases, and autoimmune disorders. Its ability to specifically target CD328/SIGLEC7 allows for a deeper understanding of its involvement in these diseases and potential therapeutic applications.
In addition to its use in basic research, this antibody has also shown promising results in clinical studies. It has been used in diagnostic assays to detect CD328/SIGLEC7 expression in patient samples, providing valuable information for disease diagnosis and treatment.
With its exceptional specificity, sensitivity, and versatility, the Anti-Human CD328/SIGLEC7 Antibody (SAA2438) is a must-have for any biotech researcher studying the immune system. Its reliable performance and proven track record make it a top choice for those looking to gain a deeper understanding of CD328/SIGLEC7 and its role in various diseases.
Order your Anti-Human CD328/SIGLEC7 Antibody (SAA2438) today and take your biotech research to the next level. Trust in its exceptional performance and see the difference it can make in your experiments.
ProteoGenix catalogue number ARO-A22885. For research use only.
Target: Sialic acid-binding Ig-like lectin 7, Siglec-7, Adhesion inhibitory receptor molecule 1, AIRM-1, CDw328, D-siglec, QA79 membrane protein, p75, CD328, SIGLEC7, AIRM1; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, SPR.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | SPR |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
